Lupin launches generic contraceptive drug in US
PTI, Apr 7, 2022, 4:54 PM IST
New Delhi: Drug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market.
The Mumbai-based drug maker has launched the product in the US market under exclusive license, marketing and distribution agreement with Slayback Pharma LLC, Lupin Ltd said in a statement.
Slayback had earlier launched this product in the US in February 2021.
Merzee (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1 mg/20 mcg is a generic equivalent of Allergan Pharmaceuticals’ Taytulla capsules.
As per IQVIA MAT February 2022 data, Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules, 1 mg/20 mcg had estimated annual sales of USD 90 million in the US.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Traffic noise can increase risk of cardiovascular disease: Study
Nearsightedness is at epidemic levels – and the problem begins in childhood
Study finds genetic basis for link between depression, heart disease
World Malaria Day: WHO calls for equitable health access
What role does genetics play in breast cancer? How can genetic testing help with early breast cancer diagnosis?
MUST WATCH
Latest Additions
Bengaluru: 2 arrested in POCSO case
Goa airport receives bomb threat email, security beefed up
SC extends stay on proceedings in hate speech case against TN BJP chief K Annamalai
Ravi Varma’s ‘hitherto unseen’ portrait of his granddaughter on display in Bengaluru on April 29-30
Focus on KL Rahul to prove himself ahead Indian team selection when LSG take on MI